Hyperimmune plasma
PC/COVID-19
Phase 2 mab completed
Quick answer
Hyperimmune plasma for SARS-CoV 2 is a Phase 2 program (mab) at Design Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Design Therapeutics
- Indication
- SARS-CoV 2
- Phase
- Phase 2
- Modality
- mab
- Status
- completed